Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ni-Q is a private healthcare and medical nutrition company focused on supplying processed human donor milk for premature, low-birth-weight, and other at-risk infants. Its flagship commercial product, HDM Plus, is a shelf-stable, ready-to-feed human donor milk product marketed to hospitals, NICUs, clinics, and families when mother's own milk is unavailable. The company emphasizes proprietary donor screening, temperature-controlled logistics, post-donation forensic testing, pasteurization, and nutritional standardization designed to improve safety, convenience, and caloric consistency versus traditional frozen donor milk. Ni-Q appears to operate as a commercial-stage company rather than a therapeutics developer, with its business centered on neonatal nutrition, donor milk processing, and distribution. It is headquartered in Wilsonville, Oregon and is venture-backed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ni-Q.